Cambridge Investment Research Advisors’s Livent Corporation LTHM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-35,871
Closed -$645K 3428
2023
Q4
$645K Sell
35,871
-3,976
-10% -$61.9K ﹤0.01% 1987
2023
Q3
$734K Buy
39,847
+4,215
+12% +$96.5K ﹤0.01% 1778
2023
Q2
$977K Sell
35,632
-10,524
-23% -$252K ﹤0.01% 1627
2023
Q1
$1M Buy
46,156
+3,976
+9% +$91.9K ﹤0.01% 1575
2022
Q4
$838K Sell
42,180
-3,946
-9% -$108K ﹤0.01% 1634
2022
Q3
$1.41M Buy
46,126
+27,494
+148% +$771K 0.01% 1254
2022
Q2
$423K Sell
18,632
-1,653
-8% -$42.5K ﹤0.01% 2089
2022
Q1
$529K Buy
20,285
+4,359
+27% +$102K ﹤0.01% 2053
2021
Q4
$388K Buy
15,926
+915
+6% +$24.8K ﹤0.01% 2309
2021
Q3
$347K Sell
15,011
-5,620
-27% -$126K ﹤0.01% 2340
2021
Q2
$399K Buy
+20,631
New +$375K ﹤0.01% 2239
2021
Q1
Sell
-10,418
Closed -$196K 3013
2020
Q4
$196K Buy
+10,418
New +$145K ﹤0.01% 2486
2019
Q4
Sell
-10,668
Closed -$71K 2488
2019
Q3
$71K Buy
+10,668
New +$71.7K ﹤0.01% 2255

Other funds holding LTHM

Cambridge Investment Research Advisors's LTHM Position: Q1 2024 in Review

Cambridge Investment Research Advisors sold out of Livent Corporation (LTHM) in Q1 2024, closing a stake of 35,871 shares — an estimated $645K sold.

Cambridge Investment Research Advisors first reported a position in LTHM in Q3 2019 and held it in 13 quarters. The position peaked at $1.41M in Q3 2022. 6 funds tracked by Wall St. Rank hold LTHM as of Q1 2024.

  • Cambridge Investment Research Advisors reported no remaining Livent Corporation position as of Q1 2024 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 35,871 Livent Corporation shares in Q1 2024, an estimated $645K.
  • Cambridge Investment Research Advisors first reported a position in Livent Corporation in Q3 2019 and held it in 13 quarters.
  • Cambridge Investment Research Advisors's Livent Corporation position peaked at $1.41M in Q3 2022.
  • 6 funds tracked by Wall St. Rank held Livent Corporation as of Q1 2024.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2024, filed 24 Apr 2024.